BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21257916)

  • 1. Ivabradine reduces heart rate while preserving metabolic fluxes and energy status of healthy normoxic working hearts.
    Lauzier B; Vaillant F; Gélinas R; Bouchard B; Brownsey R; Thorin E; Tardif JC; Des Rosiers C
    Am J Physiol Heart Circ Physiol; 2011 Mar; 300(3):H845-52. PubMed ID: 21257916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ivabradine and metoprolol differentially affect cardiac glucose metabolism despite similar heart rate reduction in a mouse model of dyslipidemia.
    Vaillant F; Lauzier B; Ruiz M; Shi Y; Lachance D; Rivard ME; Bolduc V; Thorin E; Tardif JC; Des Rosiers C
    Am J Physiol Heart Circ Physiol; 2016 Oct; 311(4):H991-H1003. PubMed ID: 27496881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversing dobutamine-induced tachycardia using ivabradine increases stroke volume with neutral effect on cardiac energetics in left ventricular post-ischaemia dysfunction.
    Bakkehaug JP; Naesheim T; Torgersen Engstad E; Kildal AB; Myrmel T; How OJ
    Acta Physiol (Oxf); 2016 Oct; 218(2):78-88. PubMed ID: 27145482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ivabradine but not propranolol delays the time to onset of ischaemia-induced ventricular fibrillation by preserving myocardial metabolic energy status.
    Vaillant F; Dehina L; Dizerens N; Bui-Xuan B; Tabib A; Lauzier B; Chevalier P; Descotes J; Timour Q
    Resuscitation; 2013 Mar; 84(3):384-90. PubMed ID: 22940600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of a beta-blocker and an If current inhibitor in rabbits with myocardial infarction.
    Langenbach MR; Schmitz-Spanke S; Brockert M; Schepan M; Pomblum VJ; Gams E; Zirngibl H; Schipke JD
    J Cardiovasc Surg (Torino); 2006 Dec; 47(6):719-25. PubMed ID: 17043621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.
    Mulder P; Barbier S; Chagraoui A; Richard V; Henry JP; Lallemand F; Renet S; Lerebours G; Mahlberg-Gaudin F; Thuillez C
    Circulation; 2004 Apr; 109(13):1674-9. PubMed ID: 14981003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart rate reduction with ivabradine improves energy metabolism and mechanical function of isolated ischaemic rabbit heart.
    Ceconi C; Cargnoni A; Francolini G; Parinello G; Ferrari R
    Cardiovasc Res; 2009 Oct; 84(1):72-82. PubMed ID: 19477966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of metoprolol and ivabradine on left ventricular remodelling and Ca2+ handling in the post-infarction rat heart.
    Maczewski M; Mackiewicz U
    Cardiovasc Res; 2008 Jul; 79(1):42-51. PubMed ID: 18310678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart rate reduction with ivabradine prevents the global phenotype of left ventricular remodeling.
    Ceconi C; Comini L; Suffredini S; Stillitano F; Bouly M; Cerbai E; Mugelli A; Ferrari R
    Am J Physiol Heart Circ Physiol; 2011 Jan; 300(1):H366-73. PubMed ID: 20952661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metoprolol improves cardiac function and modulates cardiac metabolism in the streptozotocin-diabetic rat.
    Sharma V; Dhillon P; Wambolt R; Parsons H; Brownsey R; Allard MF; McNeill JH
    Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1609-20. PubMed ID: 18203848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of ivabradine, a selective heart rate-lowering agent, and propranolol on systemic and cardiac haemodynamics at rest and during exercise.
    Joannides R; Moore N; Iacob M; Compagnon P; Lerebours G; Menard JF; Thuillez C
    Br J Clin Pharmacol; 2006 Feb; 61(2):127-37. PubMed ID: 16433867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart rate-associated mechanical stress impairs carotid but not cerebral artery compliance in dyslipidemic atherosclerotic mice.
    Bolduc V; Drouin A; Gillis MA; Duquette N; Thorin-Trescases N; Frayne-Robillard I; Des Rosiers C; Tardif JC; Thorin E
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H2081-92. PubMed ID: 21926346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ivabradine: the hope for a good treatment of ischemic heart disease.
    Riccioni G
    Curr Med Chem; 2013; 20(14):1817-23. PubMed ID: 23394554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart rate reduction with ivabradine increases ischaemia-induced ventricular fibrillation threshold: role of myocyte structure and myocardial perfusion.
    Vaillant F; Dehina L; Mazzadi A; Descotes J; Chevalier P; Tabib A; Bui-Xuan B; Riera C; Belhani D; Timour Q
    Resuscitation; 2011 Aug; 82(8):1092-9. PubMed ID: 21561702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic phenotyping of the diseased rat heart using 13C-substrates and ex vivo perfusion in the working mode.
    Vincent G; Khairallah M; Bouchard B; Des Rosiers C
    Mol Cell Biochem; 2003 Jan; 242(1-2):89-99. PubMed ID: 12619870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute effect of ivabradine on heart rate and myocardial oxygen consumption in dogs with asymptomatic mitral valve degeneration.
    Pirintr P; Limprasutr V; Saengklub N; Pavinadol P; Yapao N; Limvanicharat N; Kuecharoen H; Kijtawornrat A
    Exp Anim; 2018 Nov; 67(4):441-449. PubMed ID: 29760343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmyocardial infarction remodeling and coronary reserve: effects of ivabradine and beta blockade therapy.
    Christensen LP; Zhang RL; Zheng W; Campanelli JJ; Dedkov EI; Weiss RM; Tomanek RJ
    Am J Physiol Heart Circ Physiol; 2009 Jul; 297(1):H322-30. PubMed ID: 19411283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ivabradine improves quality of life in subjects with chronic heart failure compared to treatment with β-blockers: results of a multicentric observational APULIA study.
    Riccioni G; Masciocco L; Benvenuto A; Saracino P; De Viti D; Massari F; Meliota G; Buta F; Speziale G
    Pharmacology; 2013; 92(5-6):276-80. PubMed ID: 24296869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure.
    Milliez P; Messaoudi S; Nehme J; Rodriguez C; Samuel JL; Delcayre C
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H435-41. PubMed ID: 19074674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ivabradine: an intelligent drug for the treatment of ischemic heart disease.
    Riccioni G
    Molecules; 2012 Nov; 17(11):13592-604. PubMed ID: 23159921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.